- Description
- Benefits
- Risks
- Additional information
- Research
Description
Retatrutide is a synthetic multi-receptor peptide agonist studied in laboratory environments for its role in metabolic regulation, energy balance, and hormone signalling pathways.
It is classified as a triple agonist peptide, interacting with GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors, making it a key compound in research focused on metabolic signalling, glucose regulation, and energy homeostasis.
In controlled research settings, Retatrutide is investigated for its influence on appetite regulation pathways, insulin signalling, lipid metabolism, and energy expenditure mechanisms, particularly in models examining metabolic disorders and endocrine system function.
Across Ireland and Europe, Retatrutide is commonly studied in areas such as:
- GLP-1, GIP, and glucagon receptor signalling
- Metabolic regulation and glucose homeostasis
- Energy balance and appetite signalling pathways
- Lipid metabolism and endocrine research
This product is supplied as a high-purity research peptide, intended strictly for scientific and laboratory use.
Disclaimer: This product is strictly for research purposes only and is not for human consumption.
Technical Information – Retatrutide
| Specification | Details |
|---|---|
| Product Name | Retatrutide |
| Compound Type | Synthetic multi-receptor peptide agonist |
| Functional Class | GLP-1, GIP, and glucagon receptor agonist |
| Mechanism of Action | Activates multiple metabolic hormone receptors |
| Biological Targets | GLP-1, GIP, glucagon receptors |
| Peptide Type | Multi-agonist metabolic peptide |
| Format | Lyophilised powder |
| Purity | Research-grade (high purity) |
| Storage | Refrigerated (2–8°C, protected from light) |
| Application | Laboratory research use only |
* Images for illustration purposes only
Researched Benefits & Focus Areas – Retatrutide
1. Multi-Receptor Metabolic Signalling
Retatrutide has been studied for:
- Simultaneous activation of GLP-1, GIP, and glucagon receptors
- Investigation of integrated metabolic signalling pathways
- Analysis of hormone-driven energy regulation mechanisms
Reference basis: Derived from preclinical and clinical-stage research examining multi-agonist peptides and metabolic regulation.
2. Glucose Regulation & Insulin Signalling
Research has explored:
- Influence on glucose metabolism pathways
- Interaction with insulin secretion and sensitivity mechanisms
- Regulation of glycaemic control systems in experimental models
Reference basis: Based on studies investigating incretin-based therapies and metabolic signalling pathways.
3. Energy Expenditure & Metabolic Efficiency
Retatrutide is commonly studied for:
- Regulation of energy balance and expenditure
- Investigation of metabolic efficiency and substrate utilisation
- Interaction with hormonal energy regulation systems
Reference basis: Supported by research into metabolic peptides and energy homeostasis mechanisms.
4. Appetite & Hormonal Signalling Research
- Studied for its role in appetite regulation pathways
- Explored in hormone-mediated satiety signalling models
- Investigated for interaction with central metabolic control systems
Reference basis: Derived from research into GLP-1 and related receptor pathways in metabolic regulation.
Disclaimer: These are research-based findings only. This product is not intended for human use or consumption.
Researched Risks & Considerations – Retatrutide
1. Complex Hormonal Interaction
- Acts on multiple receptor systems simultaneously
- Potential for complex and variable responses in experimental models
Reference basis: Based on studies examining multi-receptor peptide signalling and endocrine system interaction.
2. Metabolic System Effects
- May significantly influence glucose and lipid metabolism
- Potential for broad systemic metabolic changes
Reference basis: Derived from research into incretin and glucagon signalling pathways.
3. Gastrointestinal & Hormonal Pathway Influence
- Interaction with digestive and hormonal signalling systems
- Potential for variable physiological responses in models
Reference basis: Based on studies examining GLP-1 receptor activity and gastrointestinal signalling pathways.
4. Limited Long-Term Research
- Long-term effects remain under active investigation
- Primarily studied in clinical and preclinical research settings
Reference basis: Reflects the current stage of Retatrutide research.
Disclaimer: These risks are based on available research data only. This product is strictly a research peptide and not for human consumption.
Additional information
| Weight | 23 kg |
|---|---|
| Dimensions | 12 × 23 × 56 cm |
| Quantity | 1 Vial, 1 Kit (10 Vials) |
Related Products
MOTS-c 10mg
FEATURED PRODUCTS
BEST SELLING PRODUCTS
LATEST PRODUCTS
TOP RATED PRODUCTS